Oncology

BLinatumomab and iNKT in Relapsed B-Cell ALL
Conditions: B-Cell ALL; ALL (Acute B-Lymphoblastic Leukemia); Philadelphia Chromosome-Negative Lymphoblastic Leukemia; CD19-positive B-cell Acute

Interventions: Biological: Invariant Natural Killer T Cell Therapy

Sponsors: UNC Lineberger Comprehensive Cancer Center; MiNK Therapeutics

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 13, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
Trial Comparing CPDMA Versus Standard Breadloafing in WLE Specimens of Stage 1-II Cutaneous Melanoma
Conditions: Cutaneous Melanoma, Stage II; Cutaneous Melanoma; Acral Melanoma

Interventions: Diagnostic Test: Wide Local Excision

Sponsors: University of Nebraska

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 12, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
Phase II De-Escalation Study of Metronomic Decitabine/Cedazuridine Plus Venetoclax in AML
Conditions: Acute Myeloid Leukaemia (AML)

Interventions: Drug: Venetoclax, Decitabine/Cedaruridine; Drug: decitabine/cedazuridine

Sponsors: Rutgers, The State University of New Jersey

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 11, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
Biomarker Testing to Predict Radiation-Related Heart Disease in Lung Cancer Patients
Conditions: Non-Small Cell Lung Cancer; Radiation-Induced Cardiac Disease

Interventions: Diagnostic Test: Serum Pro-N-Cadherin Biomarker Assessment; Diagnostic Test: Echocardiogram

Sponsors: Duke University; National Institute of Allergy and Infectious Diseases (NIAID)

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 10, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
Trial of First-line Gemcitabine and Nab-paclitaxel With or Without L-glutamine in Advanced Pancreatic Cancer
Conditions: Pancreatic Cancer

Interventions: Drug: Gemcitabine (1000 mg/m2); Drug: Nab-paclitaxel; Drug: L-glutamine

Sponsors: Jun Gong, MD

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 9, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
US/PA/E Imaging for Early Identification of Tumor Response in Patients With Stage II-III Triple Negative Breast Cancer Receiving Neoadjuvant Immunotherapy and Chemotherapy
Conditions: Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Triple-Negative Breast Carcinoma

Interventions: Procedure: Elastography; Procedure: Magnetic Resonance Imaging; Procedure: Photoacoustic Imaging; Procedure: Ultrasound Imaging; Drug: Pembrolizumab; Drug: Carboplatin; Drug: Paclitaxel; Drug: Doxorubicin; Drug: Cyclophosphamide

Sponsors: Emory University; National Cancer Institute (NCI)

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 8, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
Pluvicto for the Treatment of African American Men With Metastatic Castration-Resistant Prostate Cancer
Conditions: Metastatic Castration-Resistant Prostate Adenocarcinoma; Stage IVB Prostate Cancer AJCC v8

Interventions: Procedure: Biopsy Procedure; Procedure: Biospecimen Collection; Procedure: Bone Scan; Procedure: Computed Tomography; Drug: Lutetium Lu 177 Vipivotide Tetraxetan; Procedure: PSMA PET Scan; Other: Questionnaire Administration; Procedure: Single Photon Emission Computed Tomography

Sponsors: Emory University; National Cancer Institute (NCI); Novartis

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 7, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
Using Silverlon® for Head and Neck Patients With Tracheostomies
Conditions: Head and Neck Cancer; Radiation Dermatitis Acute; Radiation Treatment

Interventions: Device: Silverlon®

Sponsors: State University of New York – Upstate Medical University; Bravida Medical

**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 6, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
Histotripsy in Biliary Tract Cancer
Conditions: Biliary Track Cancer

Interventions: Drug: Gemcitabine; Drug: Cisplatin; Drug: Durvalumab; Drug: Pembrolizumab; Device: Histotripsy

Sponsors: NYU Langone Health

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 5, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
The Precision Mito- Mito Map COMPASS Study
Conditions: Mitochondrial Diseases; Myalgic Encephalomyelitis Chronic Fatigue Syndrome; Post-COVID-19 Condition; Postural Orthostatic Tachycardia Syndrome; Lyme Disease; Post-Treatment Lyme Disease Syndrome; Fibromyalgia; Cancer-Related Fatigue; Neuromuscular Diseases; Fatigue; POLG-Related Disorders

Interventions: Other: Mito Map Energy Score and Home Functional Assessments

Sponsors: AI Agent Vault, Inc. d/b/a Precision Mito

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 4, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
Free Clinical Trial Updates

    #1 Best New Product in 2019
    Headache Relief Shampoo Banner Ad
    Search For Clinical Trials
      CLOSE
      Please click to geolocate button to change this value.
      SEARCHRESET
      Featured Research Centers